With the acceleration of population aging, the upgrading of medical demand, and technological innovation, the market scale of medical devices in China and globally has shown a steady growth trend and will gradually unleash tremendous potential. According to data analysis by Frost & Sullivan, the market scale of medical devices in China has been climbing year by year in recent years, and it has risen to become the world's second-largest market after the United States.
The R&D and innovation capabilities of Chinese medical devices have steadily improved. The number of innovative medical devices approved for market launch by the National Medical Products Administration (NMPA) has been increasing year by year. The overseas recognition of Chinese brands has also risen. These factors together have driven Chinese medical device companies to expand into overseas markets in search of broader growth space. Compared with the domestic market, overseas markets not only offer vast space but also tremendous growth potential in niche markets. At the same time, emerging markets have strong medical demand, providing Chinese companies with opportunities for differentiated competition. Chinese medical device products, with their advantages such as high cost-effectiveness, innovation, and brand upgrading, possess strong competitiveness. Going global for Chinese medical devices has become an inevitable trend.
Frost & Sullivan (Frost & Sullivan, abbreviated as 'Frost & Sullivan') has released the 'Blue Book on the Current Situation and Trends of China's Medical Device Internationalization in 2025' (hereinafter referred to as the Blue Book), aiming to comprehensively analyze the current situation of China's medical devices going global, market prospects, challenges and opportunities they face, etc.The Blue Book starts from the market scale of medical devices in China and globally, analyzes the driving factors for Chinese medical device enterprises to go global from three aspects: internal factors, external factors, and strategic intentions, and dissects the common strategies currently used by enterprises going global. It also analyzes various sub-sectors of medical devices and key regions for going global, delves into the opportunities and challenges for medical device enterprises going global, and proposes targeted pain points and solutions to safeguard the go-global journey of enterprises and products.
The Chinese and English versions of the 'Blue Book on the Current Situation and Trends of China's Medical Device Internationalization in 2025' have been released on the Frost & Sullivan global official website. The English version is also synchronously landing on well-known global communication agencies (such as The Associated Press), mainstream financial media (such as Yahoo Finance), top North American financial media and websites (Business Insider, Dow Jones MarketWatch, Benzinga, Wall Street Insider, etc.), and top regional media around the world. Leveraging Frost & Sullivan's professional industry analysis, global distribution network, and industrial resource network, it effectively assists Chinese enterprises in their internationalization strategy.
